NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Latest News & Postscripts

Why should I report to the Yellow Card scheme?

Posted: November 19, 2018.
Category - Medicines Update

Yellow Card Scotland has provided a summary of the importance and relevance to practice of reporting adverse drug reactions (ADRs) via the Yellow Card scheme. KEY POINTS As little as 2 or 3 reports of an ...

Read More...

Therapeutics Handbook Update Nov 2018

Posted: November 03, 2018.
Category - Medicines Update

The Adult Therapeutics Handbook content has now been updated and includes the following main changes: Respiratory System The

Read More...

DOAC Patient Information Booklet available now

Posted: October 30, 2018.
Category - Medicines Update

A Direct Oral Anticoagulant (DOAC) Patient Information Booklet and Alert Card have been developed for use across NHSGGC. This new resource is suitable for patients taking apixaban, dabigatran, edoxaban or rivaroxaban and highlights key ...

Read More...

Contraceptive Advice: Valproate Medicines

Posted: October 29, 2018.
Category - Medicines Update

Background A previous blog Drug Safety Information: valproate medicines highlighted the MHRA valproate medicines safety alert April 2018 regarding women taking valproate medicines. This article gives local expert advice...

Read More...

Formulary Update (October 2018)

Posted: October 12, 2018.
Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary

Read More...

Clozapine and risk of life-threatening constipation

Posted: October 10, 2018.
Category - Medicines Update

Key messages Constipation is a very common adverse effect of clozapine treatmentMortality rates associated with complications from clozapine-induced constipation are higher than the risk of fatal agranulocytosisThe risk o...

Read More...

Delirium: Medication Review in Acute

Posted: October 10, 2018.
Category - Medicines Update

The NHSGGC Delirium Diagnosis, Risk Reduction and Management in Acute Services guideline recommends undertaking a medication review. This blog provides advice on how to undertake a medication review using the TIME structure (see below).

Read More...

MHRA Updates Sept 18

Posted: October 09, 2018.
Category - Medicines Update

Drug Safety Update (September 2018) includes: Valproat...

Read More...

Guideline News Sept 2018

Posted: October 09, 2018.
Category - Medicines Update

Updated Adult NHSGGC Guidelines now available on StaffNet

Read More...

New Evidence Challenges Omega-3 Beliefs

Posted: October 09, 2018.
Category - Medicines Update

Key messages Clinical and cost-effective benefit of omega-3 fats is lacking NHSGGC Heart MCN supports review of patients prescribed them In July 20...

Read More...